Hydroxychloroquine Dose per Ophthalmology Guidelines and the Risk of Systemic Lupus Erythematosus Flares.
作者信息
Jorge April M, Mancini Christian, Zhou Baijun, Ho Gary, Zhang Yuqing, Costenbader Karen, Choi Hyon K
机构信息
Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston.
Division of Rheumatology, NYU Langone Health, New York.
出版信息
JAMA. 2022 Oct 11;328(14):1458-1460. doi: 10.1001/jama.2022.13591.
Abstract
摘要
相似文献
1
Hydroxychloroquine Dose per Ophthalmology Guidelines and the Risk of Systemic Lupus Erythematosus Flares.根据眼科指南的羟氯喹剂量与系统性红斑狼疮发作风险
JAMA. 2022 Oct 11;328(14):1458-1460. doi: 10.1001/jama.2022.13591.
2
Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus.根据美国眼科学会指南调整羟氯喹剂量对系统性红斑狼疮的临床影响。
Lupus Sci Med. 2020 May;7(1). doi: 10.1136/lupus-2020-000395.
3
Hydroxychloroquine: do we all see eye to eye? A single-site analysis of hydroxychloroquine dosing compared with the 2016 Revision of the American Academy of Ophthalmology guidelines.羟氯喹：我们都看法一致吗？与美国眼科学会2016年修订版指南相比的羟氯喹给药单中心分析
Lupus. 2019 Mar;28(3):438-439. doi: 10.1177/0961203319826682. Epub 2019 Feb 2.
4
Hydroxychloroquine prescription trends and predictors for excess dosing per recent ophthalmology guidelines.羟氯喹处方趋势及按近期眼科学指南过量用药的预测因素。
Arthritis Res Ther. 2018 Jul 5;20(1):133. doi: 10.1186/s13075-018-1634-8.
5
Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study.羟氯喹在系统性红斑狼疮老年患者中的停药：一项多中心回顾性研究。
Arthritis Res Ther. 2020 Aug 17;22(1):191. doi: 10.1186/s13075-020-02282-0.
6
Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.羟氯喹减量或停药后的 flares：来自系统性红斑狼疮国际协作组（SLICC） inception 队列的结果。
Ann Rheum Dis. 2022 Mar;81(3):370-378. doi: 10.1136/annrheumdis-2021-221295. Epub 2021 Dec 15.
7
Hydroxychloroquine in systemic lupus erythematosus (SLE).羟氯喹在系统性红斑狼疮（SLE）中的应用。
Expert Opin Drug Saf. 2017 Mar;16(3):411-419. doi: 10.1080/14740338.2017.1269168. Epub 2016 Dec 14.
8
Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus.羟氯喹的日剂量、羟氯喹的血药浓度与系统性红斑狼疮患者病情恶化的风险。
Lupus Sci Med. 2023 Jan;10(1). doi: 10.1136/lupus-2022-000841.
9
Clinical features of ocular damage in systemic lupus erythematosus and risk factors for hydroxychloroquine-related complications.系统性红斑狼疮患者眼部损害的临床特征及羟氯喹相关并发症的危险因素。
Surv Ophthalmol. 2024 Sep-Oct;69(5):733-742. doi: 10.1016/j.survophthal.2024.05.006. Epub 2024 May 21.
10
Impact of the revised american academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practice.修订后的美国眼科学会指南中关于羟氯喹筛查对实际操作的影响。
Am J Ophthalmol. 2013 Mar;155(3):418-428.e1. doi: 10.1016/j.ajo.2012.09.025. Epub 2012 Dec 4.
引用本文的文献
1
Refining lupus management: a comprehensive review of HCQ blood levels.优化狼疮管理：对羟氯喹血液水平的全面综述
Rheumatol Adv Pract. 2025 Jul 7;9(3):rkaf080. doi: 10.1093/rap/rkaf080. eCollection 2025.
2
Advances in precision medicine for lupus nephritis: biomarker- and AI-driven diagnosis and treatment response prediction and targeted therapies.狼疮性肾炎精准医学的进展：生物标志物和人工智能驱动的诊断、治疗反应预测及靶向治疗
EBioMedicine. 2025 Jun 3;117:105785. doi: 10.1016/j.ebiom.2025.105785.
3
Targeting autophagy in autoimmune glomerular diseases.针对自身免疫性肾小球疾病中的自噬作用
J Nephrol. 2025 Mar 19. doi: 10.1007/s40620-025-02267-9.
4
Comparison of flares in 85 patients with SLE who maintained, discontinued or reduced dose of hydroxychloroquine during a prospective study of ophthalmological screening for retinopathy (PERFOCTAPS Study).在一项针对视网膜病变进行眼科筛查的前瞻性研究（PERFOCTAPS研究）中，对85例系统性红斑狼疮患者在维持、停用或减少羟氯喹剂量期间的病情发作情况进行比较。
Lupus Sci Med. 2025 Mar 12;12(1):e001434. doi: 10.1136/lupus-2024-001434.
5
Hydroxychloroquine in patients with systemic lupus erythematosus: how much is enough?系统性红斑狼疮患者使用羟氯喹：多少剂量足够？
Lupus Sci Med. 2025 Feb 26;12(1):e001254. doi: 10.1136/lupus-2024-001254.
6
Treatment trends of systemic lupus erythematosus from 2007 to 2023 in the USA.2007年至2023年美国系统性红斑狼疮的治疗趋势
Lupus Sci Med. 2024 Dec 9;11(2):e001317. doi: 10.1136/lupus-2024-001317.
7
Anti-retinal Autoantibodies in Hydroxychloroquine Eye Toxicity.羟氯喹啉致眼毒性中的抗视网膜自身抗体
ACR Open Rheumatol. 2025 Jan;7(1):e11743. doi: 10.1002/acr2.11743. Epub 2024 Nov 7.
8
Antimalarials in Lupus Nephritis: How Strong Is the Evidence?狼疮性肾炎中的抗疟药：证据有多确凿？
Kidney360. 2024 Dec 1;5(12):1938-1947. doi: 10.34067/KID.0000000626. Epub 2024 Oct 21.
9
Therapeutic Hydroxychloroquine Blood Levels Are Associated With Fewer Hospitalizations and Possible Reduction of Health Disparities in Lupus.羟氯喹的治疗血药浓度与减少狼疮患者住院治疗相关，且可能减少健康差异。
Arthritis Care Res (Hoboken). 2024 Dec;76(12):1606-1616. doi: 10.1002/acr.25422. Epub 2024 Oct 1.
10
Antiplatelet effects of hydroxychloroquine in patients with systemic lupus erythematosus evaluated by the total thrombus-formation analysis system (T-TAS).羟氯喹对系统性红斑狼疮患者的抗血小板作用的全血栓形成分析系统（T-TAS）评估。
Lupus Sci Med. 2024 Jul 8;11(2):e001223. doi: 10.1136/lupus-2024-001223.
本文引用的文献
1
Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.羟氯喹减量或停药后的 flares：来自系统性红斑狼疮国际协作组（SLICC） inception 队列的结果。
Ann Rheum Dis. 2022 Mar;81(3):370-378. doi: 10.1136/annrheumdis-2021-221295. Epub 2021 Dec 15.
2
Measures of Adult Systemic Lupus Erythematosus: Disease Activity and Damage.成人系统性红斑狼疮的评估：疾病活动与损伤
Arthritis Care Res (Hoboken). 2020 Oct;72 Suppl 10:27-46. doi: 10.1002/acr.24221.
3
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus.2019 年更新版的 EULAR 系统性红斑狼疮治疗建议。
Ann Rheum Dis. 2019 Jun;78(6):736-745. doi: 10.1136/annrheumdis-2019-215089. Epub 2019 Mar 29.
4
Hydroxychloroquine retinopathy - implications of research advances for rheumatology care.羟氯喹视网膜病变——研究进展对风湿病学护理的影响。
Nat Rev Rheumatol. 2018 Dec;14(12):693-703. doi: 10.1038/s41584-018-0111-8.
5
Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).关于氯喹和羟氯喹视网膜病变筛查的建议（2016 年修订版）。
Ophthalmology. 2016 Jun;123(6):1386-94. doi: 10.1016/j.ophtha.2016.01.058. Epub 2016 Mar 16.
6
Combined oral contraceptives in women with systemic lupus erythematosus.系统性红斑狼疮女性使用复方口服避孕药的情况。
N Engl J Med. 2005 Dec 15;353(24):2550-8. doi: 10.1056/NEJMoa051135.
Zotero 插件